Skip to search.
 TSX Up 0.74% TSX Ventures Up 0.24%

Genomic Health, Inc. (GHDX)

-NasdaqGS
30.59 Down 0.40(1.29%) Dec 7, 4:00PM EST
|Pre-Market : 30.58 Down 0.01 (0.02%) 4:50PM EST - Nasdaq Real Time Price
Prev Close:30.99
Open:N/A
Bid:28.00 x 300
Ask:N/A
1y Target Est:32.55
Beta:0.339647
Earnings Date:Feb 8 - Feb 13 (Est.)
Day's Range:N/A - N/A
52wk Range:22.00 - 35.79
Volume:0
Avg Vol (3m):193,479
Market Cap:1.02B
P/E (ttm):N/A
EPS (ttm):-0.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
GHDXDown 1.29%1.02B
HOLXUp 0.28%10.85B
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):437.00
P/S (ttm):3.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.46
Quarterly EPS Est (Dec-16) :0.00
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-12.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback